Brief: Aroa Biosurgery Posts H1 Product Revenue NZ$39.1 Million
25/11/2024 21:43
Nov 26 (Reuters) - Aroa Biosurgery H1 product revenue NZD 39.1 million. * H1 adjusted operating expenses NZD 33.2 million * H1 product gross margin 87% * H1 adjusted EBITDA NZD -1.5 million * H1 adjusted pretax profit NZD -3.515 million * H1 gross profit NZD 33.981 million * H1 adjusted EBIT NZD -3.953 million
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million